ArticleBMC cardiovascular disorders2025
Clinical and echocardiographic outcomes of sync-atrioventricular versus nominal optimization in correlation with QRS narrowing among CRT patients.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Electrical Risk Score as a Predictor of Coronary Artery Disease.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiac resynchronization therapy (CRT) has been established as a key component in the management of patients with heart failure (HF) with reduced ejection fraction in addition to pharmacologic therapy. Several automatic algorithms have been developed to optimize the timing cycle settings in CRT, especially AV delay which was associated with improvement of the response to CRT. The present study aims to investigate whether the novel device-based SyncAV algorithm could elicit better synchrony and acute hemodynamic response.
methodsThirty-six patients (age 52.81 ± 14.45 years; 69% male; 27% with ischemic cardiomyopathy; LV ejection fraction 24.81 ± 5.87%; QRS duration173.64 ± 15.99 ms) with intact atrioventricular conduction (PR interval 184.69 ± 15.43, range 150-210 ms), left bundle branch block, undergoing CRT implantation were prospectively studied. The device was programmed to two biventricular (BiV) pacing modes after the procedure: Nominal AV delay (140/110 ms) optimization (Group A), and SyncAV algorithm with optimized offset minimizing QRS duration (QRSd) (Group B). After each setting, clinical electrocardiographic, and echocardiographic data were collected at 1- and 6-months post implantation.
resultsThe intrinsic QRSd (171.50 ± 16.32 ms) was reduced to161.17 ± 19.89 ms after 1 month and to 157.44 ± 24.51ms after 6 months among group A, However, intrinsic QRSd ( 175.78 ± 15.82 ms ) was reduced to 154.00 ± 14.62 ms after 1 month and to 141.00 ± 16.45 ms after 6 months among group B [P < 0.001 versus nominal mode]) with significant improvement in clinical and echo criteria and without QRSd prolongation in any patient.
conclusionPost-implant electrical optimization in already well-selected patients with left bundle branch block and optimized LV lead position is facilitated by patient-tailored BiV pacing adjusted to intrinsic atrioventricular timing using an automatic device- based algorithm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.